Cathie Wood's comeback could continue through the year as most of her Ark Invest funds come roaring back alongside the tech ...

So, the Palantir growth story has been all about riding the AI wave to Valhalla but, in sharp contrast, chip giant AMD’s ...

Cathie Wood and her firm ARK Invest have a propensity for high-flying tech and artificial intelligence stocks. That's why ...

Cathie Wood, chief of Ark Investment Management, often makes big bets on her target tech stocks. Sometimes, she’ll buy them ...

Valerio Baselli: Hello and welcome to Morningstar. I’m very glad to be joined today by one of the most famous names when it ...

Cathie Wood, the renowned CEO of Ark Investment Management, has made headlines once again by investing $9 million in Qualcomm Inc. This strategic move comes on the heels of the company’s impressive ...

Cathie Wood and Ark Invest sold roughly $19.4 million worth of Palantir stock on February 11 and redirected funds toward ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

In this article, we will take a look at 15 stocks in Cathie Wood’s stock portfolio. Cathie Wood is one of Wall Street’s most ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

20:40 EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) today Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

Intellia Therapeutics (NTLA): NTLA was a minutely small position in ARK's first 13F filing in 2016. The 2017-2020 time period saw the position built to a ~11.2M share position at prices between ~$ ...